Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Histologic Type × Oxaliplatin × 1 year × Clear all

Sponsor

Conditions

Colorectal Neoplasms 71 Stomach Neoplasms 58 Rectal Neoplasms 36 Colonic Neoplasms 29 Pancreatic Neoplasms 25 Esophageal Neoplasms 23 Neoplasms 19 Lymphoma, Large B-Cell, Diffuse 19 Adenocarcinoma 19 Neoplasm Metastasis 14 Cholangiocarcinoma 14 Carcinoma, Non-Small-Cell Lung 12 Adenocarcinoma Of Esophagus 12 Ovarian Neoplasms 10 Biliary Tract Neoplasms 10 Gastrointestinal Neoplasms 8 Gallbladder Neoplasms 7 Parkinson Disease 4, Autosomal Dominant Lewy Body 6 Locally Advanced Rectal Cancer 5 Recurrence 4 Lymphoma 4 Esophageal Squamous Cell Carcinoma 4 Endometrial Neoplasms 4 Carcinoma 4 Bile Duct Neoplasms 4 Advanced Solid Tumors 4 Triple Negative Breast Neoplasms 3 Peritoneal Neoplasms 3 Lymphoma, Non-Hodgkin 3 Lung Neoplasms 3

Interventions

fludarabine 4 Cisplatin 4 Pemetrexed 3 Cyclophosphamide 3 pralsetinib 2 pembrolizumab 2 fludarabine phosphate 2 durvalumab 2 cobimetinib 2 atezolizumab 2 Whole-Body Irradiation 2 Vemurafenib 2 Tacrolimus 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Paclitaxel 2 Nivolumab 2 Mycophenolic Acid 2 Mesna 2 Melphalan 2 Busulfan 2 130-nm albumin-bound paclitaxel 2 trametinib 1 spartalizumab 1 ruxolitinib 1 repotrectinib 1 ponatinib 1 pertuzumab 1 gilteritinib 1 enzalutamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡